Eli Lilly's Massive Revenue Surge Sparks Major Wall Street Upgrades

New York, Sunday, 17 May 2026.
Fueled by a staggering 56 percent surge in first-quarter revenue, analysts are aggressively raising Eli Lilly’s price targets as the company’s global dominance in weight-loss treatments accelerates.